ANVS
Price
$2.80
Change
-$0.05 (-1.75%)
Updated
Jul 11, 03:34 PM (EDT)
Capitalization
53M
33 days until earnings call
ATXS
Price
$6.48
Change
-$0.19 (-2.85%)
Updated
Jul 11, 03:46 PM (EDT)
Capitalization
382.06M
31 days until earnings call
Interact to see
Advertisement

ANVS vs ATXS

Header iconANVS vs ATXS Comparison
Open Charts ANVS vs ATXSBanner chart's image
Annovis Bio
Price$2.80
Change-$0.05 (-1.75%)
Volume$300
Capitalization53M
Astria Therapeutics
Price$6.48
Change-$0.19 (-2.85%)
Volume$884
Capitalization382.06M
ANVS vs ATXS Comparison Chart in %
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. ATXS commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Buy and ATXS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ANVS: $2.85 vs. ATXS: $6.67)
Brand notoriety: ANVS and ATXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 78% vs. ATXS: 60%
Market capitalization -- ANVS: $53M vs. ATXS: $382.06M
ANVS [@Biotechnology] is valued at $53M. ATXS’s [@Biotechnology] market capitalization is $382.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileATXS’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • ATXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANVS and ATXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while ATXS’s TA Score has 5 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 4 bearish.
  • ATXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ANVS and ATXS are a good buy in the short-term.

Price Growth

ANVS (@Biotechnology) experienced а +20.76% price change this week, while ATXS (@Biotechnology) price change was +14.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

ANVS is expected to report earnings on Nov 05, 2025.

ATXS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($382M) has a higher market cap than ANVS($53M). ATXS YTD gains are higher at: -25.391 vs. ANVS (-43.340). ANVS has higher annual earnings (EBITDA): -25.17M vs. ATXS (-124.4M). ATXS has more cash in the bank: 295M vs. ANVS (22.2M). ANVS (0) and ATXS (0) have equivalent revenues.
ANVSATXSANVS / ATXS
Capitalization53M382M14%
EBITDA-25.17M-124.4M20%
Gain YTD-43.340-25.391171%
P/E RatioN/AN/A-
Revenue00-
Total Cash22.2M295M8%
Total DebtN/A5.06M-
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSATXS
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
89%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMKBP57.15N/A
N/A
Niagara Mohawk Power Corp.
AHOTF0.34N/A
N/A
American Hotel Income Properties REIT LP
KAIKY15.36N/A
N/A
Kawasaki Kisen Kaisha, Ltd.
TKCBF5.99N/A
N/A
Tokai Carbon Company Ltd.
VIORF0.10N/A
-2.94%
VIOR INC.

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+4.78%
ADXN - ANVS
43%
Loosely correlated
-3.76%
IDYA - ANVS
38%
Loosely correlated
-0.74%
MDGL - ANVS
36%
Loosely correlated
+1.96%
ZURA - ANVS
36%
Loosely correlated
+2.96%
ATXS - ANVS
35%
Loosely correlated
-1.48%
More

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with XENE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-1.48%
XENE - ATXS
53%
Loosely correlated
+0.92%
CRNX - ATXS
53%
Loosely correlated
-1.05%
DNLI - ATXS
52%
Loosely correlated
+2.33%
ERAS - ATXS
52%
Loosely correlated
-1.30%
COGT - ATXS
52%
Loosely correlated
+4.33%
More